LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
MDA-MB-231 SB590885
0.04
uM
LJP5
 72
hr
 868 3452 3486 0.9901 0.9869
MDA-MB-231 PIK-93
0.04
uM
LJP5
 72
hr
 868 3598 3486 1.0322 1.0429
MDA-MB-231 KIN001-043
0.04
uM
LJP6
 72
hr
 868 3394 3486 0.9735 0.9647
MDA-MB-231 Alpelisib
0.04
uM
LJP5
 72
hr
 868 3540 3486 1.0155 1.0206
MDA-MB-231 Luminespib
0.04
uM
LJP5
 72
hr
 868 1038 3486 0.2978 0.0650
MDA-MB-231 A443654
0.04
uM
LJP6
 72
hr
 868 1292 3486 0.3706 0.1619
MDA-MB-231 OSI-027
0.04
uM
LJP6
 72
hr
 868 3680 3486 1.0557 1.0742
MDA-MB-231 XMD11-85h
0.04
uM
LJP6
 72
hr
 868 2646 3486 0.7591 0.6792
MDA-MB-231 HG-6-64-01
0.04
uM
LJP6
 72
hr
 868 3755 3486 1.0772 1.1028
MDA-MB-231 WH-4-025
0.04
uM
LJP5
 72
hr
 868 2822 3486 0.8094 0.7463
MDA-MB-231 WZ-4-145
0.04
uM
LJP6
 72
hr
 868 2653 3486 0.7611 0.6818
MDA-MB-231 XMD16-144
0.04
uM
LJP5
 72
hr
 868 1714 3486 0.4917 0.3232
MDA-MB-231 Brivanib
0.04
uM
LJP5
 72
hr
 868 2841 3486 0.8149 0.7535
MDA-MB-231 Buparlisib
0.04
uM
LJP5
 72
hr
 868 3829 3486 1.0985 1.1311
MDA-MB-231 BX-912
0.04
uM
LJP5
 72
hr
 868 3067 3486 0.8798 0.8400
MDA-MB-231 Canertinib
0.04
uM
LJP6
 72
hr
 868 3831 3486 1.0989 1.1317
MDA-MB-231 Celastrol
0.04
uM
LJP6
 72
hr
 868 3721 3486 1.0675 1.0899
MDA-MB-231 CGP60474
0.04
uM
LJP5
 72
hr
 868 2398 3486 0.6878 0.5843
MDA-MB-231 CGP60474
0.04
uM
LJP6
 72
hr
 868 870 3486 0.2495 0.0007
MDA-MB-231 CHIR-99021
0.04
uM
LJP6
 72
hr
 868 3091 3486 0.8866 0.8490
MDA-MB-231 CP724714
0.04
uM
LJP5
 72
hr
 868 2656 3486 0.7620 0.6831
MDA-MB-231 CP466722
0.04
uM
LJP5
 72
hr
 868 3815 3486 1.0943 1.1256
MDA-MB-231 Crizotinib
0.04
uM
LJP5
 72
hr
 868 2483 3486 0.7122 0.6168
MDA-MB-231 Momelotinib
0.04
uM
LJP5
 72
hr
 868 2772 3486 0.7951 0.7272
MDA-MB-231 Dasatinib
0.04
uM
LJP5
 72
hr
 868 1648 3486 0.4728 0.2980